Sanofi
Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the same
Last updated:
Abstract:
The invention relates to a live-attenuated yellow fever virus strain adapted to grow on Vero cells from a parent yellow fever virus 17D substrain that is not adapted to grow on Vero cells, wherein said live-attenuated yellow fever virus strain is less neurovirulent than said parent yellow fever virus 17D substrain.
Status:
Grant
Type:
Utility
Filling date:
5 Nov 2021
Issue date:
27 Sep 2022